The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Machine learning model integrating CT radiomics and circulating microRNAs to predict residual disease histology in metastatic non-seminoma testicular cancer (mNSTC).
 
Guliz Ozgun
No Relationships to Disclose
 
Neda Abdalvand
No Relationships to Disclose
 
Gizem Ozcan
No Relationships to Disclose
 
Ka Mun Nip
No Relationships to Disclose
 
Nastaran Khazamipour
No Relationships to Disclose
 
Arman Rahmim
No Relationships to Disclose
 
Robert Bell
No Relationships to Disclose
 
Maryam Soleimani
Honoraria - Alpha-9 Theranostics; AstraZeneca Canada; Bayer; Ipsen; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Pfizer
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Novartis Canada Pharmaceuticals Inc
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Corinne Maurice-Dror
Honoraria - Eisai; Janssen; Janssen; Merck; Pfizer; Pfizer
Consulting or Advisory Role - Biomica
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Janssen
 
Kim Chi
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; BMS GmbH & Co. KG; Janssen; Merck; Novartis; Pfizer; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; POINT Biopharma; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Bernhard Eigl
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; EMD Serono/Merck; Gilead Sciences; Janssen; Merck; Pfizer; Roche Canada; Seagen
Consulting or Advisory Role - EMD Serono; Gilead Sciences
Travel, Accommodations, Expenses - EMD Serono
 
Craig Nichols
No Relationships to Disclose
 
Christian Kollmannsberger
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; Merck; Merck KGaA; Pfizer; Seagen
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen; Merck; Merck KGaA; Pfizer; Seagen
Travel, Accommodations, Expenses - AAA Canada; Ipsen; Janssen Oncology; Pfizer
 
Ren Yuan
No Relationships to Disclose
 
Lucia Nappi
Honoraria - Bayer; Ipsen; Janssen; Pfizer; Tersera
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - IVERMECTIN ANALOGUE COMPOUND THERAPEUTICS FOR HEAT SHOCK PROTEIN-27 (HSP27) INHIBITION, METHODS AND USES ASSOCIATED THEREWITH provisional number: 62/756,707
Travel, Accommodations, Expenses - Pfizer